| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 02/04/2002 | CA2354253A1 Polypeptides or nucleic acids encoding these of a family of g-protein coupled receptors and their use for the diagnosis or treatment of disorders, for example skin disorders and their use for the identification of pharmacologically active substances |
| 02/04/2002 | CA2352369A1 Power amplifier sharing in a wireless communication system with transmit diversity |
| 02/01/2002 | WO2001007617A1 Human homologue of bovine neuroendocrine secretory protein, nesp55, polynucleotides and uses thereof linked with obesity |
| 02/01/2002 | CA2380942A1 Human homologue of bovine neuroendocrine secretory protein, nesp55, polynucleotides and uses thereof linked with obesity |
| 01/31/2002 | WO2002008453A2 Canine toxicity genes |
| 01/31/2002 | WO2002008417A1 Process for producing recombinant protein |
| 01/31/2002 | WO2002008416A1 Method of preparing antibody by gene immunization |
| 01/31/2002 | WO2002008399A2 Human kinases |
| 01/31/2002 | WO2002008396A2 Human proteases |
| 01/31/2002 | WO2002008383A2 Sp110, a polypeptide component of the nuclear body |
| 01/31/2002 | WO2002008381A2 Common polymorphism in scn5a implicated in drug-induced cardiac arrhythmia |
| 01/31/2002 | WO2002008293A2 Multivalent target binding protein |
| 01/31/2002 | WO2002008292A2 Human monoclonal antibody against hepatitis c virus e2 glycoprotein |
| 01/31/2002 | WO2002008290A1 Dog melanin-concentrating hormone receptor |
| 01/31/2002 | WO2002008288A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/31/2002 | WO2002008286A2 Zinc finger domain recognition code and uses thereof |
| 01/31/2002 | WO2002008285A2 Il-17 molecules and uses thereof |
| 01/31/2002 | WO2002008284A2 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis |
| 01/31/2002 | WO2002008272A2 High affinity soluble interleukin-18 receptor |
| 01/31/2002 | WO2002008271A1 Novel fibroblast growth factor (fgf23) and methods for use |
| 01/31/2002 | WO2002008257A2 Siglec (sialic acid-binding ig-related lectin) polypeptides and uses thereof |
| 01/31/2002 | WO2002008255A2 Cell cycle proteins and mitosis-associated molecules |
| 01/31/2002 | WO2002008253A2 A NOVEL MEMBER OF THE EphA RECEPTOR FAMILY |
| 01/31/2002 | WO2002008252A2 Novel protein containing ring finger domaine r1p4 |
| 01/31/2002 | WO2002007514A2 Glycosylated vegf-b and method for increasing the amount of soluble vegf-b |
| 01/31/2002 | WO2001080873A3 Thrombopoietin receptor modulating peptide |
| 01/31/2002 | WO2001077321A3 Identification of a human gaba transporter |
| 01/31/2002 | WO2001048485A3 Selecting library members capable of binding to epitopes |
| 01/31/2002 | WO2001040473A3 Pseudomonas aeruginosa antigens |
| 01/31/2002 | WO2001034801A3 Recombinant gelatin in vaccines |
| 01/31/2002 | WO2000059941A9 Purposeful movement of human migratory cells away from an agent source |
| 01/31/2002 | WO2000056900A3 Promoter sequences derived from fusarium venenatum and uses thereof |
| 01/31/2002 | US20020012992 Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor |
| 01/31/2002 | US20020012991 Nutrient broth; for use in the generation of monoclonal antibodies and preferential particles; for use in maintenance of cell viability |
| 01/31/2002 | US20020012983 Novel subunits of nadh dehydrogenase |
| 01/31/2002 | US20020012982 Recovering preferential protein from solution; incubate protein with matrix, separate and reccover preferential protein |
| 01/31/2002 | US20020012980 Transforming cellulose to lactic acid; incubate cellulose with cellulase and microorganism, recover lactic acid |
| 01/31/2002 | US20020012966 18 Human secreted proteins |
| 01/31/2002 | US20020012965 Nucleotide sequences coding prfeerential polypeptides for use in the diagnosis and treatment of brain disorders and injury |
| 01/31/2002 | US20020012963 Nucleotide sequences coding preferential peptides; for use in diagnosing and treatment of allergies |
| 01/31/2002 | US20020012962 Nucleotide sequences coding fusion protein for use in the treatment of osteoporosis, cancers, and cachexia |
| 01/31/2002 | US20020012959 Genetic engineering |
| 01/31/2002 | US20020012909 Small functional units of antibody heavy chain variable regions |
| 01/31/2002 | US20020012672 For immunization of domestic fowl, such as turkeys and chickens, against E. coli infections (Colibacillosis) |
| 01/31/2002 | US20020012669 For detecting a genetic abnormality, cancer |
| 01/31/2002 | US20020012664 Combining agent to be tested, antibody or antigen-binding fragment which binds to amino terminal domain of mammalian CC-chemokine receptor 2, mammalian CC-chemokine receptor 2 or ligand-binding variant, measuring binding |
| 01/31/2002 | US20020012654 For production, expression and recovery of harvestable polypeptides, screening compounds for metabolic activity, studying enteric disease and for use in a bio-artificial liver device |
| 01/31/2002 | CA2418215A1 Novel fibroblast growth factor (fgf23) and methods for use |
| 01/31/2002 | CA2418198A1 Novel protein containing ring finger domaine r1p4 |
| 01/31/2002 | CA2417508A1 Glycosylated vegf-b and method for increasing the amount of soluble vegf-b |
| 01/31/2002 | CA2417223A1 A novel member of the epha receptor family |
| 01/31/2002 | CA2417185A1 Multivalent target binding protein |
| 01/31/2002 | CA2416713A1 Novel siglecs and uses thereof |
| 01/31/2002 | CA2416691A1 Proteases |
| 01/31/2002 | CA2416683A1 Dog melanin-concentrating hormone receptor |
| 01/31/2002 | CA2416664A1 Zinc finger domain recognition code and uses thereof |
| 01/31/2002 | CA2416657A1 Fh-binding protein of streptococcus pneumoniae |
| 01/31/2002 | CA2416538A1 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis |
| 01/31/2002 | CA2416456A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/31/2002 | CA2416414A1 Human kinases |
| 01/31/2002 | CA2415077A1 Cell cycle proteins and mitosis-associated molecules |
| 01/31/2002 | CA2412626A1 Il-17 molecules and uses thereof |
| 01/30/2002 | EP1176210A1 Preparation containing cell extract for synthesizing cell-free protein and means for synthesizing cell-free protein |
| 01/30/2002 | EP1176201A2 Platelet-specific chimeric immunoglobulin |
| 01/30/2002 | EP1176195A1 Method for controlling the activity of immunologically functional molecule |
| 01/30/2002 | EP1175909A2 Therapeutic methods and compositions based on serrate proteins and nucleic acids |
| 01/30/2002 | EP1175513A1 MinK-RELATED GENES, FORMATION OF POTASSIUM CHANNELS AND ASSOCIATION WITH CARDIAC ARRHYTHMIA |
| 01/30/2002 | EP1175504A1 Dna encoding the human vanilloid receptor vr1 |
| 01/30/2002 | EP1175503A1 49 human secreted proteins |
| 01/30/2002 | EP1175502A1 Halo- or hydroxy-substituted nocathiacin antibiotics |
| 01/30/2002 | EP1175498A2 Nucleic acid-antibody conjugate for delivering a foreign nucleic acid in cells |
| 01/30/2002 | EP1175491A1 Recombinant protein uk114 and its use in therapy and diagnostics |
| 01/30/2002 | EP1175490A2 Tyrosine kinase substrate (tks) proteins |
| 01/30/2002 | EP1175446A1 Human antibodies that bind human il-12 and methods for producing |
| 01/30/2002 | EP1175445A1 Specific antibodies and antibody fragments for tgfbeta1 |
| 01/30/2002 | EP1175444A1 Amino-terminal modified parathyroid hormone (pth) analogs |
| 01/30/2002 | EP1175440A1 48 human secreted proteins |
| 01/30/2002 | EP1175439A1 49 human secreted proteins |
| 01/30/2002 | EP1175438A1 62 human secreted proteins |
| 01/30/2002 | EP1175435A1 Cephaibols, novel antiparasitics from acremonium tubakii, method for the production and the utilization thereof |
| 01/30/2002 | EP1175227A1 Monoclonal antibody directed against cells of human renal cell carcinoma |
| 01/30/2002 | EP0668913B1 Adenovirus-mediated gene transfer to cardiac and vascular smooth muscle |
| 01/30/2002 | EP0596979B1 Recombinant plant viral nucleic acids |
| 01/30/2002 | EP0528857B1 New bacillus thuringiensis strain and its gene encoding insecticidal toxin |
| 01/30/2002 | EP0497922B1 Infective protein delivery system |
| 01/30/2002 | CN1333837A Methods for producing polypeptides in aspergillus mutant cells |
| 01/30/2002 | CN1333832A Compounds and methods for treatment and diagnosis of chlamydial infection |
| 01/30/2002 | CN1333831A Polymorphic loci that differentiate escherichia coli 0157:H7 from other strains |
| 01/30/2002 | CN1333828A Compositions and methods for increasing bone mineralization |
| 01/30/2002 | CN1333819A Method for high level expression of active lymphotoxin-betareceptor immunoglobulin |
| 01/30/2002 | CN1333785A Interferon-beta fusion proteins and uses |
| 01/30/2002 | CN1333692A I (mycobacterium tuberculosis) superoxide dismutase |
| 01/30/2002 | CN1333373A Process for preparing exciting type anti-human CD40 monoclonal antibody and application thereof |
| 01/30/2002 | CN1333372A Process for preparing potide zinc easy absorbed in human body |
| 01/29/2002 | US6342596 Molecular regulatory circuits to achieve sustained activation of genes of interest by a single stress |
| 01/29/2002 | US6342594 Determination of metastatic potential of cancer cells in test samples |
| 01/29/2002 | US6342584 Antiproliferative, anticarcinogenic, antitumor, antiinflammatory, and antimetastasis agents; diabetes, restenosis, rheumatoid arthritis treatment; genetic engineering |
| 01/29/2002 | US6342392 Isolation of human and murine wild-type int6 gene cdna; cancer diagnosis; gene and immunotherapy; vaccines; gene expression |
| 01/29/2002 | US6342374 Human collagenase inhibitor, recombinant vector system for using same and recombinant-DNA method for the manufacture of same |
| 01/29/2002 | US6342372 Culture to form protein using nutrients, isolation, culture of cells for expression of recombitant protein |